Obstructive sleep apnoea and type 2 diabetes

Abd A. Tahrani*, Asad Ali

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)


With the growing prevalence of obesity, the burden of type 2 diabetes is increasing. Obstructive sleep apnoea (OSA) is a very common medical condition that is associated with increased risk of cardiovascular disease and mortality. Obesity is a common risk factor for OSA and type 2 diabetes and hence it is not surprising that OSA and type 2 diabetes are interlinked. OSA has been shown to be an independent risk factor for the development of incident pre-diabetes/type 2 diabetes. OSA is also associated with worse glycaemic control and vascular disease in patients with type 2 diabetes. However, evidence for the benefits of OSA treatment in patients with type 2 diabetes is still lacking. The aim of this article is to provide an overview of OSA, the relationships between OSA and dysglycaemia and the impact of OSA in patients with type 2 diabetes, highlighting recent advances in the field.

Original languageEnglish
Pages (from-to)43-50
Number of pages8
JournalEuropean Endocrinology
Issue number1
Publication statusPublished - 2014


  • Cardiovascular disease
  • Diabetes
  • Glycated haemoglobin
  • Hypertension
  • Impaired glucose tolerance
  • Nephropathy
  • Neuropathy
  • Obesity
  • Pre-diabetes
  • Retinopathy
  • Sleep apnoea

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Endocrine and Autonomic Systems


Dive into the research topics of 'Obstructive sleep apnoea and type 2 diabetes'. Together they form a unique fingerprint.

Cite this